Cour Pharmaceuticals Development
Kamil Rusin is a Quality Assurance Specialist at Cour Pharmaceuticals Development Company, Inc. since April 2023, with a strong background in quality control and assurance spanning several leading companies. Previously, Kamil served as a Senior Investigations Specialist in Quality Control at Novartis Gene Therapies from March 2020 to April 2023, and as a Quality Control Specialist at AveXis, Inc. from August 2018 to March 2020. Kamil's experience also includes working as a QC Chemist at Procter & Gamble from January 2015 to August 2018 and as a Quality Control Chemist at Avlon Industries Inc from June 2014 to January 2015. Kamil's early career involved a role as a Quality Control Inspector at Avlon from February 2014 to June 2014. Kamil Rusin holds a Bachelor's Degree in Biology/Biological Sciences from Saint Xavier University, completed between 2012 and 2014.
This person is not in any teams
Cour Pharmaceuticals Development
Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.